T
TriReme Medical
Novel stent technologies for the treatment of coronary artery bifurcations
About TriReme Medical
TriReme Medical, a subsidiary of QT Vascular, specializes in the development and distribution of advanced angioplasty balloons, including the Chocolate and Glider families. These products are designed for the minimally invasive treatment of vascular diseases, offering an alternative to traditional stents which can lead to complications such as scar tissue buildup, metal fatigue, and the need for long-term blood thinning medications. The company serves healthcare providers and patients globally, operating in the medical device market with a focus on vascular health. TriReme Medical generates revenue through the sale of its innovative medical devices, which are designed to improve patient outcomes and reduce the long-term costs associated with vascular treatments.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 16
- Open positions
- None listed
- Dealroom signal
- 75.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Surgery, Cardiology and cardiovascular, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES EOther financing | Nov 2012 | $18M | $72M | Luminor Capital | — |
| SERIES DOther financing | Oct 2010 | $17M | $68M | Adams Street Partners · Three Arch Partners · Bio*One Capital · EDBI | — |
Growth signals
Latest recorded traffic for TriReme Medical is 70 monthly website visits, down 72% over the last three months. TriReme Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
TriReme Medical in the Pleasanton ecosystem
The TriReme Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later5 investors entered at this stage
Three Arch Partners
Adams Street Partners
EDBI
Bio*One Capital
Luminor Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about TriReme Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See TriReme Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









